That change about the regulatory authority in the ovarian trial and that the product was exported from the US is similar to the change made in an Italian trial that some thought might be DCVax and was brought to the board's attention a little while back. A change in that trial history showed the product was recently listed as imported from the US where previously it was not. The product had a description that sounded very much like DCVax but no product name was given. Best wishes.
News 
Market Data 
Discover 
AI
